Rapalogix Health, Inc.
Rapalogix is advancing a portfolio of TORC1-selective therapies and pro-longevity skincare products, addressing skin aging and disease at the root to extend skin healthspan.
Funding history
About Rapalogix Health, Inc.
How much funding has Rapalogix Health, Inc. raised?
Rapalogix Health, Inc. has raised $19.1M in total funding. The most recent round was Series A.
Where is Rapalogix Health, Inc. headquartered?
Rapalogix Health, Inc. is headquartered in Carlsbad, CA.
What does Rapalogix Health, Inc. do?
Rapalogix is advancing a portfolio of TORC1-selective therapies and pro-longevity skincare products, addressing skin aging and disease at the root to extend skin healthspan.
What problem does Rapalogix Health, Inc. solve?
Current dermatology treatments only address symptoms rather than the biological root causes of skin aging and disease.
What's Rapalogix Health, Inc.'s solution?
They develop TORC1-targeted dermatology therapeutics and pro-longevity skincare that rebalance mTOR, a master regulator of cellular health, to restore skin function.
What makes Rapalogix Health, Inc. different?
Proprietary compounds selectively targeting TORC1 dysregulation underlying dermatologic conditions.
What makes Rapalogix Health, Inc. notable?
Rapalogix Health was founded by scientist Rahul Mehta, PhD, alongside renowned dermatologist Dr. Doris Day and Brent Saunders, the former CEO of Allergan and Bausch + Lomb; the company raised a $20M Series A in 2026.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.